The risk of tachyarrhythmias in patients with moderate-to-severe chronic kidney disease receiving tiotropium bromide

Int J Cardiol. 2015 Oct 15:197:105-6. doi: 10.1016/j.ijcard.2015.06.051. Epub 2015 Jun 20.

¹ Chest Centre, University Hospital Aintree, Liverpool, UK; Athens Breath Centre, Athens, Greece; Respiratory Assembly, Hellenic Society for the Advancement of Biomedical Research, Athens, Greece. Electronic address: [email protected].
² Respiratory Assembly, Hellenic Society for the Advancement of Biomedical Research, Athens, Greece; The Zena and Michael A. Wiener Cardiovascular Institute, The Icahn School of Medicine at Mount Sinai, New York, USA.
³ Athens Breath Centre, Athens, Greece; Respiratory Assembly, Hellenic Society for the Advancement of Biomedical Research, Athens, Greece.
⁴ Athens Breath Centre, Athens, Greece.

No abstract available

Keywords: Arrhythmia; COPD; Human; Mortality; Therapeutics; Tiotropium.

Publication types